{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:15:33Z","timestamp":1792818933714,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K20720"],"award-info":[{"award-number":["21K20720"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s12012-025-09970-w","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:58:56Z","timestamp":1739995136000},"page":"498-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular Toxicity Profile of Macrolides Investigated Using VigiBase Data: A Pharmacovigilance Study"],"prefix":"10.1007","volume":"25","author":[{"given":"Yuki","family":"Kono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Niimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuka","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Izawa-Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"15","key":"9970_CR1","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1056\/NEJMc1212055","volume":"368","author":"LA Hicks","year":"2013","unstructured":"Hicks, L. A., Taylor, T. H., Jr., & Hunkler, R. J. (2013). U.S. outpatient antibiotic prescribing 2010. The New England Journal of Medicine, 368(15), 1461\u20131462. https:\/\/doi.org\/10.1056\/NEJMc1212055","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"9970_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jiac.2018.01.003","volume":"24","author":"A Tsutsui","year":"2018","unstructured":"Tsutsui, A., Yahara, K., & Shibayama, K. (2018). Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. Journal of Infection and Chemotherapy, 24(6), 414\u2013421. https:\/\/doi.org\/10.1016\/j.jiac.2018.01.003","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"20","key":"9970_CR3","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","volume":"66","author":"YJ Cheng","year":"2015","unstructured":"Cheng, Y. J., Nie, X. Y., Chen, X. M., Lin, X. X., Tang, K., Zeng, W. T., Mei, W. Y., Liu, L. J., Long, M., Yao, F. J., Liu, J., Liao, X. X., Du, Z. M., Dong, Y. G., Ma, H., Xiao, H. P., & Wu, S. H. (2015). The role of macrolide antibiotics in increasing cardiovascular risk. Journal of the American College of Cardiology, 66(20), 2173\u20132184. https:\/\/doi.org\/10.1016\/j.jacc.2015.09.029","journal-title":"Journal of the American College of Cardiology"},{"issue":"20","key":"9970_CR4","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"WA Ray","year":"2012","unstructured":"Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012). Azithromycin and the risk of cardiovascular death. The New England Journal of Medicine, 366(20), 1881\u20131890. https:\/\/doi.org\/10.1056\/NEJMoa1003833","journal-title":"The New England Journal of Medicine"},{"key":"9970_CR5","unstructured":"US Food and Drug Administration. (2013). FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms. Retrieved September 2, 2024, from https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-azithromycin-zithromax-or-zmax-and-risk-potentially-fatal-heart"},{"key":"9970_CR6","unstructured":"US Food and Drug Administration. (2018). FDA Drug Safety Communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease. Retrieved September 2, 2024, from https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-review-finds-additional-data-supports-potential-increased-long"},{"issue":"1","key":"9970_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1124\/jpet.102.037911","volume":"303","author":"P Milberg","year":"2002","unstructured":"Milberg, P., Eckardt, L., Bruns, H. J., Biertz, J., Ramtin, S., Reinsch, N., Fleischer, D., Kirchhof, P., Fabritz, L., Breithardt, G., & Haverkamp, W. (2002). Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. Journal of Pharmacology and Experimental Therapeutics, 303(1), 218\u2013225. https:\/\/doi.org\/10.1124\/jpet.102.037911","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"9970_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/bdrb.21107","volume":"101","author":"MF Nilsson","year":"2014","unstructured":"Nilsson, M. F., & Webster, W. S. (2014). Effects of macrolide antibiotics on rat embryonic heart function in vitro. Birth Defects Research Part B Developmental and Reproductive Toxicology, 101(2), 189\u2013198. https:\/\/doi.org\/10.1002\/bdrb.21107","journal-title":"Birth Defects Research Part B Developmental and Reproductive Toxicology"},{"issue":"7","key":"9970_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/ph14070597","volume":"14","author":"NE Farag","year":"2021","unstructured":"Farag, N. E., El-Kherbetawy, M. K., Ismail, H. M., Abdelrady, A. M., Toraih, E. A., Abdelbasset, W. K., Lashine, R. M., El-Dosoky, M., Abed, S. Y., Ibraheem, K. M., Fawzy, M. S., & Zaitone, S. A. (2021). Differential effect of three macrolide antibiotics on cardiac pathology and electrophysiology in a myocardial infarction rat model: Influence on sodium Nav1.5 channel expression. Pharmaceuticals (Basel), 14(7), 597. https:\/\/doi.org\/10.3390\/ph14070597","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"9970_CR10","doi-asserted-by":"publisher","first-page":"e00438","DOI":"10.1128\/AAC.00438-18","volume":"62","author":"E Gorelik","year":"2018","unstructured":"Gorelik, E., Masarwa, R., Perlman, A., Rotshild, V., Muszkat, M., & Matok, I. (2018). Systematic review, meta-analysis, and network meta-analysis of the cardiovascular safety of macrolides. Antimicrobial Agents and Chemotherapy, 62(6), e00438-e518. https:\/\/doi.org\/10.1128\/AAC.00438-18","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"9970_CR11","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","volume":"19","author":"JE Salem","year":"2018","unstructured":"Salem, J. E., Manouchehri, A., Moey, M., Lebrun-Vignes, B., Bastarache, L., Pariente, A., Gobert, A., Spano, J. P., Balko, J. M., Bonaca, M. P., Roden, D. M., Johnson, D. B., & Moslehi, J. J. (2018). Cardiovascular toxicities associated with immune checkpoint inhibitors: An observational, retrospective, pharmacovigilance study. Lancet Oncology, 19(12), 1579\u20131589. https:\/\/doi.org\/10.1016\/S1470-2045(18)30608-9","journal-title":"Lancet Oncology"},{"issue":"18","key":"9970_CR12","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.jacc.2021.08.044","volume":"78","author":"A Goldman","year":"2021","unstructured":"Goldman, A., Maor, E., Bomze, D., Liu, J. E., Herrmann, J., Fein, J., Steingart, R. M., Mahmood, S. S., Schaffer, W. L., Perales, M. A., & Shouval, R. (2021). Adverse cardiovascular and pulmonary events associated with chimeric antigen receptor T-cell therapy. Journal of the American College of Cardiology, 78(18), 1800\u20131813. https:\/\/doi.org\/10.1016\/j.jacc.2021.08.044","journal-title":"Journal of the American College of Cardiology"},{"key":"9970_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab347","author":"Y Noguchi","year":"2021","unstructured":"Noguchi, Y., Tachi, T., & Teramachi, H. (2021). Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Briefings in Bioinformatics. https:\/\/doi.org\/10.1093\/bib\/bbab347","journal-title":"Briefings in Bioinformatics"},{"key":"9970_CR14","unstructured":"R Core Team. R 2020 A language and environment for statistical computing. R Foundation for Statistical Computing"},{"issue":"2","key":"9970_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMcp0706513","volume":"358","author":"DM Roden","year":"2008","unstructured":"Roden, D. M. (2008). Long-QT syndrome. The New England Journal of Medicine, 358(2), 169\u2013176. https:\/\/doi.org\/10.1056\/NEJMcp0706513","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"9970_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0018578719882323","volume":"56","author":"R Neha","year":"2021","unstructured":"Neha, R., Subeesh, V., Beulah, E., Gouri, N., & Maheswari, E. (2021). Existence of notoriety bias in FDA adverse event reporting system database and its impact on signal strength. Hospital Pharmacy, 56(3), 152\u2013158. https:\/\/doi.org\/10.1177\/0018578719882323","journal-title":"Hospital Pharmacy"},{"issue":"20","key":"9970_CR17","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy, D., Larson, M. G., Vasan, R. S., Kannel, W. B., & Ho, K. K. (1996). The progression from hypertension to congestive heart failure. JAMA, 275(20), 1557\u20131562.","journal-title":"JAMA"},{"issue":"18","key":"9970_CR18","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","volume":"119","author":"E Anter","year":"2009","unstructured":"Anter, E., Jessup, M., & Callans, D. J. (2009). Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic. Circulation, 119(18), 2516\u20132525. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.821306","journal-title":"Circulation"},{"issue":"7","key":"9970_CR19","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1161\/01.cir.96.7.2455","volume":"96","author":"BM Psaty","year":"1997","unstructured":"Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., White, R., Furberg, C. D., & Rautaharju, P. M. (1997). Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 96(7), 2455\u20132461. https:\/\/doi.org\/10.1161\/01.cir.96.7.2455","journal-title":"Circulation"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-09970-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-025-09970-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-09970-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T14:39:38Z","timestamp":1741358378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-025-09970-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["9970"],"URL":"https:\/\/doi.org\/10.1007\/s12012-025-09970-w","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Tokushima University Hospital (approval number: 4492).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All procedures involving human participants adhered to ethical standards set by the institutional research committee and followed the principles of the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal Participants"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}